Skip to Content

Alcaftadine ophthalmic Pregnancy and Breastfeeding Warnings

Alcaftadine ophthalmic is also known as: Lastacaft

Medically reviewed on October 23, 2017

Alcaftadine ophthalmic Pregnancy Warnings

Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

See references

Alcaftadine ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Lastacaft (alcaftadine ophthalmic)." Vistakon, div of Johnson and Johnson Optical, Jacksonville, FL.

References for breastfeeding information

  1. "Product Information. Lastacaft (alcaftadine ophthalmic)." Vistakon, div of Johnson and Johnson Optical, Jacksonville, FL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide